Work

Abstract PS5-04-06: Current and Emerging Treatment Patterns for Patients with Residual Disease Post-Neoadjuvant Therapy in Early-Stage Triple Receptor-Negative Breast Cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-04-06

Authors: A. Haiderali, J. R. Earla, P. Kondaparthi, J. Nathani, S. Sharma

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), PAREXEL International (India)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129513349

Cites:

Cited by:

Related to: